• SOURCE

    September 2016

    An entirely new material was introduced this month that increases the quality of synthetic small-diameter nanofiber vascular grafts. The new nanofiber material reduces the risk of blood clots and complications in heart surgery patients.

    A scientific team headed by Professor David Lukáš has been working to develop the material for the past five years in cooperation with the scientific team of Associate Professor Lukáš Čapek. The scientists developed the new material as part of a project of the Czech Ministry of Health in cooperation with scientists of the Faculty of Military Health Science of the University of Defence in Hradec Králové and with physicians of the Cardiac Surgery Clinic.

    The need to develop a new material was expressed by cardiology and cardiac surgery departments, which are constantly faced with a lack of autografts, i.e. grafts using the patient’s own tissue that are the first choice during cardiac surgery. Unfortunately, in a number of cases, as autografts cannot be used, an alternative must be found and blocked vessels are ultimately bypassed with artificial vessels. While this method works well in larger diameter artificial vascular grafts, it presents a problem in vessels less than 6mm in diameter, where artificial grafts threaten the lives of patients because of potential blood clots. This task was very demanding, considering the complicated nature of vascular tissue, which contains several types of cells.

    Now, after many years of research a team of scientists has been able to create a double-layered vascular graft where the nanofiber structure very closely mimics the extracellular matrix in the vasculature.

    Synthetic nanofiber vascular grafts are produced by electrostatically creating fibers from biocompatible and biodegradable materials. Very important advances have been made with respect to biodegradability (the gradual breaking down or degradation of substances in the body). The materials used in the body of the patient degrade over a number of months, which ensures sufficient time for gradual replacement with fully functional tissue, i.e. remodeling.

    For the time being, very careful animal testing is underway that is necessary before moving on to clinical trials. As in similar cases, we cannot rush the process because it is a very high-risk application and the lives of patients will be at risk during testing. Nevertheless, if scientists are able to successfully conclude clinical testing, there is a great chance here to reduce the health risks and complications of cardiac surgery.

    New developments in the field of nanotechnology – a method that restores vision >>

    Nanotechnology – Leading Way to Medicinal Innovation >>

    Nanotechnology Allowing Image Capture with Atomically Thin Materials >>

     
     

    No comments

    Be the first one to leave a comment.

    Post a Comment


     

     

    Latest Posts

    Latest Video

     
     

    LATEST POSTS

    Toward a ‘smart’ patch that automatically delivers insulin when needed

      SOURCE (Nanowerk News) Treatment for certain diabetes cases involves constant monitoring of blood-glucose levels and daily insulin shots. But…

    Irish Researchers make Stem Cell Cancer Breakthrough

    Scientists discover way to make radiotherapy more effective in oesophageal cancer care Central to the work, which involved Trinity College…

    MIT Introduces Adaptable 3D Printing, Revolutionary Technique to Transform 3D Printed Objects

    SOURCE Researchers at the Massachusetts Institute of Technology (MIT) have developed a 3D printing technique which effectively allows users to…

    Chinese company Jala Group using 3D printed skin to test cosmetics for Asian market

    SOURCE Jala Group, a Chinese cosmetics company, has used 3D bioprinting technology to print artificial “Asian skin,” complete with dermis and…

    Historic HIV vaccine efficacy study underway in South Africa

    The first HIV vaccine efficacy study to launch anywhere in 7 years is testing whether an experimental vaccine safely prevents…

    When Pot Meets Pain and Insomnia: Why Many Fibromyalgia Patients Swear by Medical Marijuana

      Fibromyalgia is a painful condition that over three million Americans suffer from. It causes widespread muscle pain and tenderness…

    Nanoarray sniffs out and distinguishes multiple diseases

    SOURCE “Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules” ACS Nano Before modern…

    Cardiac stem cell infusion could be effective therapy for the most common type of heart failure

    SOURCE Cardiac stem cells could be an effective treatment for a common but difficult-to-treat type of heart failure, a new…